These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31616290)

  • 1. The Trials and Tribulations of Structure Assisted Design of K
    Shim H; Brown BM; Singh L; Singh V; Fettinger JC; Yarov-Yarovoy V; Wulff H
    Front Pharmacol; 2019; 10():972. PubMed ID: 31616290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-
    Brown BM; Shim H; Zhang M; Yarov-Yarovoy V; Wulff H
    Mol Pharmacol; 2017 Oct; 92(4):469-480. PubMed ID: 28760780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
    Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
    Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
    Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
    Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of
    Kloza M; Baranowska-Kuczko M; Toczek M; Kusaczuk M; Sadowska O; Kasacka I; Kozłowska H
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.
    Brown BM; Shim H; Christophersen P; Wulff H
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():219-240. PubMed ID: 31337271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
    Damkjaer M; Nielsen G; Bodendiek S; Staehr M; Gramsbergen JB; de Wit C; Jensen BL; Simonsen U; Bie P; Wulff H; Köhler R
    Br J Pharmacol; 2012 Jan; 165(1):223-34. PubMed ID: 21699504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.
    Hasenau AL; Nielsen G; Morisseau C; Hammock BD; Wulff H; Köhler R
    Acta Physiol (Oxf); 2011 Sep; 203(1):117-26. PubMed ID: 21362152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Channelopathy of small- and intermediate-conductance Ca
    Nam YW; Downey M; Rahman MA; Cui M; Zhang M
    Acta Pharmacol Sin; 2023 Feb; 44(2):259-267. PubMed ID: 35715699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process.
    Morales P; Garneau L; Klein H; Lavoie MF; Parent L; Sauvé R
    J Gen Physiol; 2013 Jul; 142(1):37-60. PubMed ID: 23797421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).
    Christophersen P; Wulff H
    Channels (Austin); 2015; 9(6):336-43. PubMed ID: 26217968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SKA-31, an activator of endothelial Ca
    Khaddaj-Mallat R; Mathew John C; Braun AP
    Eur J Pharmacol; 2018 Jul; 831():60-67. PubMed ID: 29753043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.
    Oliván-Viguera A; Valero MS; Coleman N; Brown BM; Laría C; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Wulff H; Badorrey R; Köhler R
    Mol Pharmacol; 2015 Feb; 87(2):338-48. PubMed ID: 25468883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat.
    Khaddaj Mallat R; Mathew John C; Mishra RC; Kendrick DJ; Braun AP
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K
    Burg S; Shapiro S; Peretz A; Haimov E; Redko B; Yeheskel A; Simhaev L; Engel H; Raveh A; Ben-Bassat A; Murninkas M; Polak R; Haitin Y; Etzion Y; Attali B
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2202926119. PubMed ID: 35969786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKA-31, an activator of Ca
    John CM; Khaddaj Mallat R; Mishra RC; George G; Singh V; Turnbull JD; Umeshappa CS; Kendrick DJ; Kim T; Fauzi FM; Visser F; Fedak PWM; Wulff H; Braun AP
    Pharmacol Res; 2020 Jan; 151():104539. PubMed ID: 31707036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K
    Orfali R; AlFaiz A; Rahman MA; Lau L; Nam YW; Zhang M
    Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets.
    Wulff H; Köhler R
    J Cardiovasc Pharmacol; 2013 Feb; 61(2):102-12. PubMed ID: 23107876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels.
    Mishra RC; Wulff H; Hill MA; Braun AP
    J Cardiovasc Pharmacol; 2015 Jul; 66(1):118-27. PubMed ID: 25815673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Channelopathy-causing mutations in the S
    Orfali R; Nam YW; Nguyen HM; Rahman MA; Yang G; Cui M; Wulff H; Zhang M
    Cell Calcium; 2022 Mar; 102():102538. PubMed ID: 35030515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.